{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:02:54Z","timestamp":1782975774622,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>X-linked hypophosphatemia (XLH) is a rare genetic disorder characterized by impaired phosphate metabolism, leading to rickets and growth failure. Delayed diagnosis may worsen growth outcomes, particularly in settings with limited access to specialized care. This study evaluated determinants of final height in a Brazilian cohort, focusing on age at diagnosis and baseline growth status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational cohort study included 41 patients with molecularly confirmed XLH followed at a tertiary referral center in Brazil between 1971 and 2025. Anthropometric and clinical data were extracted from medical records. Final height analysis was restricted to 20 patients treated exclusively with conventional therapy. Correlations were assessed using Spearman coefficients, and multivariable linear regression was performed to identify independent predictors of final height Z score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At diagnosis, the mean height-for-age Z-score was \u22121.90\u2009\u00b1\u20091.56, indicating significant baseline growth impairment. Age at diagnosis was inversely correlated with height-for-age Z-score (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.77;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02), while no correlation was observed with BMI-for-age Z-score. Among patients who reached final height, the mean final height Z-score was \u22122.96\u2009\u00b1\u20091.15. In multivariable analysis, height-for-age Z-score at diagnosis (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.10; 95% CI 0.04 to 0.15;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009), age at diagnosis (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u2009\u22120.04; 95% CI \u22120.07 to \u22120.02;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007), and target height Z-score (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.37; 95% CI 0.15 to 0.59;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) were independently associated with final height. Sex and BMI-for-age Z-score were not significantly associated with the outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Final height in XLH is influenced by a combination of genetic potential, baseline growth impairment, and timing of diagnosis. Delayed diagnosis is associated with greater growth deficits and suboptimal adult height, even under conventional therapy. These findings highlight the importance of early recognition and provide a benchmark for evaluating growth outcomes in the era of targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1845607","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:04Z","timestamp":1782970444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of final height in X-linked hypophosphatemia: impact of diagnostic delay and baseline growth in a Brazilian cohort"],"prefix":"10.3389","volume":"14","author":[{"given":"Mauro","family":"Borghi","sequence":"first","affiliation":[{"name":"Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa de S\u00e3o Paulo (FCMSCSP)","place":["S\u00e3o Paulo, SP, Brazil"]},{"name":"Unidade de Endocrinologia Pedi\u00e1trica, Ambulat\u00f3rio de Metabolismo \u00d3sseo, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo (ISCMSP)","place":["S\u00e3o Paulo, SP, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro Borghi","family":"Moreira","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Universidade de Santo Amaro (UNISA)","place":["S\u00e3o Paulo, SP, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo Muniz","family":"da Silva","sequence":"additional","affiliation":[{"name":"Rede D\u2019Or, D\u2019Or Institute for Research and Education (IDOR)","place":["S\u00e3o Paulo, SP, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41581-024-00926-x","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1210\/clinem\/dgaf170","article-title":"X-Linked hypophosphatemia management in adults: an international working group clinical practice guideline","volume":"110","author":"Khan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"104958","DOI":"10.1016\/j.ejmg.2024.104958","article-title":"Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets","volume":"70","author":"Baroncelli","year":"2024","journal-title":"Eur J Med Genet"},{"key":"B4","first-page":"6","article-title":"X-Linked hypophosphatemia","volume-title":"GeneReviews\u00ae","author":"Ruppe","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1215952","DOI":"10.3389\/fped.2023.1215952","article-title":"A genetic study of a Brazilian cohort of patients with X-linked hypophosphatemia reveals no correlation between genotype and phenotype","volume":"11","author":"Borghi","year":"2023","journal-title":"Front Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics15010091","article-title":"Clinical, radiographic, and molecular analysis of patients with X-linked hypophosphatemic rickets: looking for phenotype\u2013genotype correlation","volume":"15","author":"Olivas-Valdez","year":"2025","journal-title":"Diagnostics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0140-6736(89)91559-6","article-title":"Hypophosphataemic rickets: final height and clinical symptoms in adults","volume":"334","author":"Stickler Gunnar","year":"1989","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s40618-025-02611-7","article-title":"Experts\u2019 consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan","volume":"48","author":"Baroncelli","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00223-025-01374-w","article-title":"The diagnosis and therapy of XLH","volume":"116","author":"B\u00f6ckmann","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1210\/jcem.76.4.8473393","article-title":"Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia","volume":"76","author":"Friedman","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1067\/mpd.2001.108955","article-title":"Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets","volume":"138","author":"Baroncelli","year":"2001","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1210\/clinem\/dgab729","article-title":"Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia","volume":"107","author":"Linglart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO Child growth standards based on length\/height, weight and age","volume":"95","author":"de Onis","year":"2006","journal-title":"Acta Paediatr"},{"key":"B15","first-page":"1","article-title":"CDC Growth charts: united States","author":"Kuczmarski","year":"2000","journal-title":"Adv Data"},{"key":"B16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13023-022-02590-5","article-title":"Growth hormone treatment improves final height in children with X-linked hypophosphatemia","volume":"17","author":"Andr\u00e9","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: pART II - binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"M\u00e4kitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1530\/EC-19-0481","article-title":"Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia","volume":"9","author":"Zhukouskaya","year":"2020","journal-title":"Endocr Connect"},{"key":"B21","doi-asserted-by":"publisher","first-page":"bvad116","DOI":"10.1210\/jendso\/bvad116","article-title":"Circulating levels of leptin and lipocalin-2 in patients with X-linked hypophosphatemia","volume":"7","author":"Simpson","year":"2023","journal-title":"J Endocr Soc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-021-01729-0","article-title":"Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population","volume":"16","author":"Rodr\u00edguez-Rubio","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1590\/1413-812320182410.01612019","article-title":"From the search for diagnosis to treatment uncertainties: challenges of care for rare genetic diseases in Brazil","volume":"24","author":"Iriart","year":"2019","journal-title":"Cien Saude Colet"},{"key":"B24","volume-title":"Ordinance No. 199, January 30, 2014. National Policy for Comprehensive Care of People with Rare Diseases","year":"2014"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1210\/clinem\/dgaa495","article-title":"Growth curves for children with X-linked hypophosphatemia","volume":"105","author":"Mao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.3390\/jcm14217496","article-title":"X-Linked hypophosphatemia in a family cohort: clinical variability, genetic confirmation and modern therapeutic perspectives","volume":"14","author":"Popa","year":"2025","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1507\/endocrj.47.163","article-title":"Final height of Japanese patients with X-linked hypophosphatemic rickets. Effect of vitamin D and phosphate therapy","volume":"47","author":"Miyamoto","year":"2000","journal-title":"Endocr J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1845607\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:05Z","timestamp":1782970445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1845607\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":28,"alternative-id":["10.3389\/fped.2026.1845607"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1845607","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1845607"}}